Bibliography from
Bruce M. Carruthers, MD; Anil Kumar Jain, MD; Kenny L. De Meirleir, MD, PhD; Daniel L. Peterson, MD; Nancy G. Klimas, MD; A. Martin Lerner, MD; Alison C. Bested, MD; Pierre Flor-Henry, MD; Pradip Joshi, MD; A.C. Peter Powles, MRACP, FRACP; Jeffrey A. Sherkey, MD; Margorie I. van de Sande, BEd
"Canadian Consensus Document for Diagnosing and Treating M.E./CFS"
Journal of Chronic Fatigue Syndrome, 2003.[Note: A shorter version of the bibliography from the Carruthers-van de Sande summary of the Consensus Document, can be found at: http://www.cfids-me.org/cfscc/canbib06.html.]
Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, et al. Frequent HHV-6 antibody and HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. C Clin Virol 16(3):179-191, May 2000.
Bates DW, Schmitt W, Buchwald D, Ware NC, Lee J, Thoyer E, Mornish RJ, Komaroff AL. Prevalence of fatigue and Chronic Fatigue Syndrome in a primary care practice. Arch of Internal Med 153:2759-2765, 1993.
Behan PO, Behan WMH, Bell EJ. The post viral fatigue syndrome – an analysis of findings in 50 cases. J Infect 10:211-222, 1985.
Bell IR, Baldwin CM, Schwartz GEW. Illness from low levels of environmental chemical: relevance to chronic fatigue syndrome and fibromyalgia. Am J Med 105 (3A):74S-82S.
Boda WL, Natelson BH, Sisto SA, Tapp WN. Gait abnormalities in patients with the chronic fatigue syndrome. J Neurol Sci 131(2):156-161, Aug. 1995.
Bouholaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally-mediated hypotension and the chronic fatigue syndrome. Journal of the American Medical Association 274 (12):961-967 Sept. 27, 1995.
Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes virus type 6 infection. Ann Intern Med 116(2):103-113, 1992.
Centers for Disease Control and Prevention: The Facts about Chronic Fatigue Syndrome. US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Infectious Diseases, Atlanta 1995.
Centers for Disease Control and Prevention: Chronic Fatigue Syndrome. US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Infectious Disease, Atlanta 1998.
Choppa PC, Vojdani A, Tagle C, Andrin R, Magoto L. Multiplex PCR for the detection of mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol Cell Probes 12 (5):301-308, 1998.
Codero DL, Sisto SA, Tapp WN, et al. Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. Clin Auton Res 6(6):329-333, 1994.
Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. Q J. Med 88:767-773, 1995.
De Becker, P, Roeykens J, Reynders M, et al. Exercise capacity in chronic fatigue syndrome. Arch Intern Med 160 (21):3270-3277, Nov. 27, 2000.
De Lange F, Kalkman J, Bleijenberg G, et al. Gray matter volume reduction in the chronic fatigue syndrome. NeuroImage 26:777-781,2005.
De Meirleir K, Bisbal C, Campine I, De Becker P,k Salehzada T, Demettre E, Lebleu B. A 36 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 108 (2):99-105, 2000.
De Meirleir K, De Becker P, Campine I. Blood transfusion and chronic fatigue syndrome. Abstract. Presented at the CFS Conference, Sydney, Australia, 1999.
Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci 840:684-697, May 1, 1998.
Di Luca D, Zorzenon M, Mirandola P, Colle R, Botta GA, Cassai E, HHV-6 and HHV-7 in CFS. J Clin Microbiol 1995; 33:1660-1661.
Fischer B., Le Bon O, Hoffmann G, et al. Sleep anomalies in the chroni fatigue syndrome. A comorbid study. Neuropsychobiol 35(3):115-122, 1997.
Fukuda K, Straus SE, Hickie I et al. Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Annals Med 121:953-959, 1994.
Glaser R, Kiecolt-Glaser J. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 105(3A):34S-42S.
Goldberg B, Editors of Alternative Medicine Digest. Chronic Fatigue, Fibromyalgia & Environmental Illness. Future Medicine Publishing, Inc., Tiburon, CA. 1998; pp. 290-211.
Holmes GP, Kaplan JE, Stewart MD, Hunt B, Pinsky, PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA May 1 1987; 257:17:2997-2302.
Holmes MJ, Diack DS, Easingwood RA, Cross JP, Carlisle B. Electron microscopic immuno-cytological profiles in chronic fatigue syndrome. J Psychia Res 31(1):115-122, 1997.
Hyde BM. Are Myalgic Encephaloyelitis and Chronic Fatigue Syndrome synonymous terms? Paper presented at ME/CFS Conference in New South Wales, Australia. Feb. 1998.
Hyde BM, Bastien S, Jain A. Post-Infectious, Acute Onset M.E./CFS (Post-Viral Fatigue Syndrome). In: The clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Editors: Hyde BM, Goldstein J, Levine P. The Nightingale Research Foundation, Ottawa, Chp. 4; pp. 25-36, 1992.
Ichise M, Salit I, Abbey S, et al. Assessment of regional cerebral perfusion by Tc-HMPAO SPECT in Chronic Fatigue Syndrome. Nuclear Med Commun 13:767-772, 1992.
Inbar O, Dlin R, Rotstein A, et al. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Scie Sports Exer 33(9):1463-1470, Sept. 2001.
Jason LA, Richman, JA, Rademaker AW, Rademaker AW, Jordan KM, Pioplys AV, Taylor RR, McCready W. A Community-based study of Chronic Fatigue Syndrome. Arch Intern Med 159:2129-2147, Oct. 1999.
Jason LA, Torres-Harding SR, Jurgens A, Helgerson J. Comparing the Fukuda et al. Criteria and the Canadian Case Definition for Chronic Fatigue syndrome, J of CFS 12 (1):27-52, 2004.
Jones JF, Ray CG, Minnich IL, et al. Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985; 102:1-7.
Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndromes: a systematic review. QJ Med 90:223-233, 1997.
Kaushik N, Fear D, Richards SCM et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 58:826-832, 2005.
Komaroff AL. The biology of the Chronic Fatigue Syndrome. Amer J Med 108:99-105, Feb 2000.
La Manca JJ, Sisto SA, DeLuca, J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. J Inter Med 250:234-240,2001.
Lange G, Holodny AI, Lee HJ, et al. Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome. Appl Neuropsychol 8(1):23-30, 2001.
Lange G, Stefferne J, Cook DB, et al. Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: A BOLD fMRI study of verbal working memory. Neuroimage 26(2):513-24, June 1, 2005.
Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in chronic fatigue syndrome. Am J Med 105(3A):50S-53S, 1998.
Lerner AM, Goldstein J, Chang CH, Zervos M, Fitzgerald JT, Dworkin JH, et al. Cardiac involvement in patients with chronic fatigue syndrome as documented with Holter and biopsy data in Birmingham, Michigan, 1991-1993. Infect Dis Clin Pract 6:327-333, 1997.
Lerner AM, Zervos M, Dworkin HJ, et al. New cardiomyopathy: pilot study of intravenous Ganciclovir in a subset of the chronic fatigue syndrome. Infec Dis in Clin Pract 6:110-117, 1997.
Lerner AM, Zervos M, Dworkin JH, Chang CH, O’Neill W. A unified theory of the cause of chronic fatigue syndrome. Infect Dis Clin Pract 6:239-243, 1997.
Lloyd AR, Hickie I, Boughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 153:522-528, 1990.
Lloyd AR, Wakefield D, Boughton C, Swyer J. What is Myalgic encephalomyelitis? Lancet 1988 (8597):1286-1287.
Martin WJ. Detection of RNA sequences in cultures of a stealth virus isolated from the cerebrospinal fluid of a health care worker with chronic fatigue syndrome. Pathobiol 65:15-18, 1997.
Martin WJ. Cellular sequences in stealth viruses. Pathobiol 1998: 66(2):53-8.
Martin WJ. Stealth adaptation of an African green monkey simian cytomegalovirus. Exp Mol Pathol 1999 66 (1):3-7, April 1999.
McArdle A, McArdle F, Jackson MJ, Page SF, Fahal I, Edwards RH. Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome. Clin Sci (Lond) 90 (4):295-300, April 1996.
McGarry F, Gow J, Behan PO. Entervirus in the chronic fatigue syndrome. Ann Intern Med 120 (11):927-973, June 1994.
Nicholson GL, Nasralla MY, Franco AR, Nicolson NL, Erwin R, Ngwenya R, Berns PA. Diagnosis and integrative treatment of intracellular bacterial infections in chronic fatigue and fibromyalgia syndromes, Gulf War illness, rheumatoid arthritis and other chronic illnesses. Clin Pract Altern Med 1(2); 42-102, 2000.
Nicholson GL, Nasralla MY, Franco AR, De Meirleir K, Nicolson NL, Ngwenya R, Haier J. Role of mycoplasmal infections in fatigue illnesses: chronic fatigue and fibromyalgia syndromes, Gulf War Illness and rheumatoid arthritis. J of CFS 6 (3/4):23-39, 2000.
Okada T, Tanaka M, Kuratsune H, et al. Mechanisms underlying fatigue: A voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 4:14, 2004.
Peckerman A, LaManca JJ, Dahl KA, et al. Abnormal impedance cardiography predicts symptom severity in Chronic Fatigue Syndrome. Amer J Med Science 326(2):55-60, Aug 2003.
Roelens S, Herst CV, D’Haese A, et al. G-actin cleavagae parallels 2-5A-Dependent Rnase L cleavage in peripheral blood mononuclear cells-relevance to a possible serum-based screening test. J of CFS 8 (3/4):63-82, 2001.
Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirol 1995; 38(5):269-273.
Sheperd C. Pacing and exercise in chronic fatigue syndrome. Physiother 87(8):395-396, Aug 2001.
Snell CF, Vanness JM, Stayer DR, Stevens SR. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS). In Vivo 19(2):387-90, Mar-Apr. 2005
Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue syndrome. Amer J Med Sci 321:163-167, Mar. 2001.
Streeten DH, Tomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med 320(1):1-8, Jul 2000.
Suhadolnik RJ, Peterson DL, Cheney PR, Horvath SF, Reichenbach NL, O’Brien K, et al. Biochemical dysregulation of the 2-5A synthetase/RNase L antiviral defense pathway in chronic fatigue syndrome. J of CFS 5(3/4):223-242, 1999.
Suhadolnik RJ, Reichenbach NL, Hitzges P, Adelson ME, Peterson DL, Cheney PR, Salvato P, Thompson C, Loveless M, Muller WG, Schroder HC, Strayer DR, Carer WA. Changes in the 2-5A synthetase/R Nase L antiviral pathway in a controlled clinical trial with poly(1)-poly(C12U) in chronic fatigue syndrome. In Vivo 8:599-604, 1994.
Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Muller WEG, Schroder HC, Carter WA, Strayer DR. Upregulation of the 2-5A synthetase/Rnase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18 (Suppl):S96-S104.
Suhadolnik RJ, Peterson DL, O’Brien K, Cheney PR, Herst CVT, Reichenbach NL, et al. Biochemical evidence for a novel low molecular weight 2-5A dependent RNase L in Chronic Fatigue Syndrome. J Interferon Cytokine Res 17:377-385, 1997.
Tirelli U, Chierichetti F, Tavio M, et al. Brain positron emission toography (PET) in chronic fatigue syndrome: preliminary data [in process citation]. Amer J Med 105 (3A):trS-t8S, Sept. 28, 1998.
Vojdani A, Choppa PC, Lapp CS. Downregulation of Rnase-L inhibitor correlates with upregulation of interferon- induced proteins (2-5A synthetase and Rnase L) in patients with chronic fatigue immune dysfunction syndrome. J Clin Lab Immunol 50 (1):1-16, 1998.
Wallace HL 2nd, Natelson B, Gause W, Hay J. Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 6(2):216-223, March 1999.
Wessely S, Nimnuan C, Sharp M. Functional somatic syndromes: one or many? Lancet 354(9182):936-939, Sept 11, 1999.
White PD, Thomas JM, Arness J, et al. The existence of a fatigue syndrome after glandular fever. Psychol Med. 25(5):907-916, 1995.
Yalcin S, Kuratsune H, Yamaguchi K, Kitani T, Yamanishi K. Prevalence of HHV-6 variants A and B in patients with CFS. Microbiol Immunol 38:587-590, 1994.
Return to Consensus petition links.